Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15252640 | 0.80 | SLC22A6 (0.30) | SLC22A6 | |
| SCHEMBL7798753 | 0.76 | MEN1 (0.30) | — | |
| Hydrochloric Acid SCHEMBL18546812 | 0.74 | — | — | |
| SCHEMBL4735588 | 0.72 | SLC22A6 (0.33) | SLC22A6 | |
| SCHEMBL28669334 | 0.72 | SLC22A6 (0.36) | SLC22A6 | |
| Acrylic Acid SCHEMBL8583541 | 0.71 | LMNA (0.31) | — | |
| SCHEMBL23442991 | 0.68 | GRIK1 (0.35) | SLC22A6 | |
| SCHEMBL2059592 | 0.68 | SLC22A6 (0.33) | SLC22A6 | |
| SCHEMBL28994413 | 0.68 | SLC22A6 (0.33) | SLC22A6 | |
| SCHEMBL24968779 | 0.68 | SLC22A6 (0.33) | SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139520-B1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RES LTD (US) | 2013-08-21 | — | — | EP | disclosed |
| US-20110124734-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | ALCON RESEARCH, LTD. (US) | 2011-05-26 | — | — | US | disclosed |
| US-20110060044-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2011-03-10 | — | — | US | disclosed |
| US-20100210730-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | ALCON RESEARCH, LTD. (US) | 2010-08-19 | — | — | US | disclosed |
| EP-2139520-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | Alcon Research, Ltd. (US) | 2010-01-06 | — | — | EP | disclosed |
| EP-2139521-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | Alcon Research, Ltd. (US) | 2010-01-06 | — | — | EP | disclosed |
| EP-2139518-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | Alcon Research, Ltd. (US) | 2010-01-06 | — | — | EP | disclosed |
| EP-2139519-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | Alcon Research, Ltd. (US) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008137444-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | ALCON RESEARCH, LTD. (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008134694-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008134692-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2008134687-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | WO | disclosed |
| US-20080275126-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080275121-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080275123-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080275122-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210730-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | IL4I1, FPR1, METTL14 | SLC22A6 2260/4885 |
| US-20080275126-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | AADAT, BCAT2, ASNS | SLC22A6 1547/4885 |
| US-20080275121-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | BCAT1, BCAT2, ASNS | SLC22A6 2328/4885 |
| US-20110124734-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | BCAT1, BCAT2, ASNS | SLC22A6 2328/4885 |
| US-20080275122-A1 | N-HALOGENATED AMINO ACID FORMULATIONS WITH ANTI-INFLAMMATORY COMPOUNDS | IL4I1, FPR1, METTL14 | SLC22A6 2260/4885 |
| US-20080275123-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | BCAT1, BCAT2, SLC7A1 | SLC22A6 547/4885 |
| US-20110060044-A1 | ALIPHATIC ACID-CONTAINING N-HALOGENATED AMINO ACID FORMULATIONS | AADAT, BCAT2, ASNS | SLC22A6 1547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.